Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study

The aim of this study was to identify predictors of clinical events after XIENCE V (Abbott Vascular, Santa Clara, California) stenting. The XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System [EECSS] USA Post-Approval) study is a prospective, multicenter, Food and Drug Administration-req...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JACC. Cardiovascular interventions 2012-06, Vol.5 (6), p.626-635
Hauptverfasser:	Naidu, Srihari S, Krucoff, Mitchell W, Rutledge, David R, Mao, Vivian W, Zhao, Weiying, Zheng, Qing, Wilburn, Olivia, Sudhir, Krishnankutty, Simonton, Charles, Hermiller, James B
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty, Balloon, Coronary - adverse effects Angioplasty, Balloon, Coronary - instrumentation Angioplasty, Balloon, Coronary - mortality Cardiovascular Agents - administration & dosage Coronary Artery Disease - mortality Coronary Artery Disease - therapy Coronary Thrombosis - etiology Coronary Thrombosis - mortality Drug Therapy, Combination Drug-Eluting Stents Everolimus Female Humans Incidence Kaplan-Meier Estimate Male Middle Aged Multivariate Analysis Myocardial Infarction - etiology Myocardial Infarction - mortality Platelet Aggregation Inhibitors - administration & dosage Proportional Hazards Models Prospective Studies Prosthesis Design Risk Assessment Risk Factors Sirolimus - administration & dosage Sirolimus - analogs & derivatives Time Factors Treatment Outcome United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!